临床医学工程
臨床醫學工程
림상의학공정
CLINICAL MEDICAL ENGINEERING
2014年
8期
965-966,969
,共3页
黄乐升%雷秀霞%龙幼敏%李莉%陈惠玲%徐邦牢
黃樂升%雷秀霞%龍幼敏%李莉%陳惠玲%徐邦牢
황악승%뢰수하%룡유민%리리%진혜령%서방뢰
慢性乙肝(CHB)%e--CHB%e+-CHB%视黄醇结合蛋白(RBP)%HBV DNA%白蛋白
慢性乙肝(CHB)%e--CHB%e+-CHB%視黃醇結閤蛋白(RBP)%HBV DNA%白蛋白
만성을간(CHB)%e--CHB%e+-CHB%시황순결합단백(RBP)%HBV DNA%백단백
Chronic hepatitis B (CHB)%e--CHB%e+-CHB%Retinol binding protein (RBP)%HBV DNA%Albumin (ALB)
目的:通过检测慢性乙肝患者(CHB)血清中视黄醇结合蛋白(RBP)、HBV DNA载量和白蛋白(ALB)的变化,研究上述指标在监测肝损害的相关意义及临床价值。方法收集我院402例慢性乙肝患者的血清标本,根据临床分型分为e--CHB组和e+-CHB组。测定血清RBP、HBV DNA载量和ALB水平关系。结果①HBV DAN:e--CHB组载量(5.04±1.55)比e+-CHB组载量(6.83±1.48)低(t=11.73,P<0.01),有统计学意义。②血清RBP和ALB水平:e--CHB组(RBP:14.37±11.07;ALB:30.85±8.9)比e+-CHB组(RBP:17.12±8.28;ALB:32.24±4.26)低(t=2.85,P<0.05; t=2.06,P<0.05),有统计学意义。③e--CHB组随着HBV DNA载量的升高血清RBP和ALB水平不断降低,高、中拷贝组与低拷贝组比较有统计学意义(P<0.05);而e+-CHB组HBV DNA载量变化与血清RBP和ALB水平变化关系不明显。结论根据慢性乙肝患者(CHB)临床分型,血清HBV DNA载量水平与RBP和ALB水平存在不同的动态变化。对于e+-CHB患者HBV DNA载量变化与上述肝脏损害指标无显著相关性。e--CHB患者HBV DNA载量变化与肝脏损程度明显相关。另外,血清RBP比ALB更能体现肝功能的损害水平,在肝功能损害上RBP优于ALB。
目的:通過檢測慢性乙肝患者(CHB)血清中視黃醇結閤蛋白(RBP)、HBV DNA載量和白蛋白(ALB)的變化,研究上述指標在鑑測肝損害的相關意義及臨床價值。方法收集我院402例慢性乙肝患者的血清標本,根據臨床分型分為e--CHB組和e+-CHB組。測定血清RBP、HBV DNA載量和ALB水平關繫。結果①HBV DAN:e--CHB組載量(5.04±1.55)比e+-CHB組載量(6.83±1.48)低(t=11.73,P<0.01),有統計學意義。②血清RBP和ALB水平:e--CHB組(RBP:14.37±11.07;ALB:30.85±8.9)比e+-CHB組(RBP:17.12±8.28;ALB:32.24±4.26)低(t=2.85,P<0.05; t=2.06,P<0.05),有統計學意義。③e--CHB組隨著HBV DNA載量的升高血清RBP和ALB水平不斷降低,高、中拷貝組與低拷貝組比較有統計學意義(P<0.05);而e+-CHB組HBV DNA載量變化與血清RBP和ALB水平變化關繫不明顯。結論根據慢性乙肝患者(CHB)臨床分型,血清HBV DNA載量水平與RBP和ALB水平存在不同的動態變化。對于e+-CHB患者HBV DNA載量變化與上述肝髒損害指標無顯著相關性。e--CHB患者HBV DNA載量變化與肝髒損程度明顯相關。另外,血清RBP比ALB更能體現肝功能的損害水平,在肝功能損害上RBP優于ALB。
목적:통과검측만성을간환자(CHB)혈청중시황순결합단백(RBP)、HBV DNA재량화백단백(ALB)적변화,연구상술지표재감측간손해적상관의의급림상개치。방법수집아원402례만성을간환자적혈청표본,근거림상분형분위e--CHB조화e+-CHB조。측정혈청RBP、HBV DNA재량화ALB수평관계。결과①HBV DAN:e--CHB조재량(5.04±1.55)비e+-CHB조재량(6.83±1.48)저(t=11.73,P<0.01),유통계학의의。②혈청RBP화ALB수평:e--CHB조(RBP:14.37±11.07;ALB:30.85±8.9)비e+-CHB조(RBP:17.12±8.28;ALB:32.24±4.26)저(t=2.85,P<0.05; t=2.06,P<0.05),유통계학의의。③e--CHB조수착HBV DNA재량적승고혈청RBP화ALB수평불단강저,고、중고패조여저고패조비교유통계학의의(P<0.05);이e+-CHB조HBV DNA재량변화여혈청RBP화ALB수평변화관계불명현。결론근거만성을간환자(CHB)림상분형,혈청HBV DNA재량수평여RBP화ALB수평존재불동적동태변화。대우e+-CHB환자HBV DNA재량변화여상술간장손해지표무현저상관성。e--CHB환자HBV DNA재량변화여간장손정도명현상관。령외,혈청RBP비ALB경능체현간공능적손해수평,재간공능손해상RBP우우ALB。
Objective Through the detection of changes of serum RBP, HBV DNA load and ALB in patients with CHB, we research the related significance and clinical value of the above indicators in monitoring liver damage. Methods We collected serum specimens of 402 cases of CHB patients, and divided into e--CHB and e+-CHB group according to clinical classification to determine the level relations of serum RBP, HBV DNA load and ALB. Results The results showed that the HBV DNA load of e--CHB group (5.04±1.55) was lower than that of e+-CHB group (6.83±1.48) (t=11.73, P<0.01), which was of statistical significance. The levels of serum RBP and ALB of e--CHB group (RBP:14.37±11.07;ALB:30.85±8.9) were lower than those of e+-CHB group (RBP:17.12±8.28;ALB:32.24±4.26) low (t=2.85, P<0.05;t=2.06, P<0.05), which were of statistical significance. The levels of serum RBP and ALB of e--CHB group decreased while HBV DNA load increased. The high and medium copy groups were more statistically significant compared with low copy group (P<0.05). And changes of HBV DNA load of e+-CHB group were not obvious with the changes of serum RBP and ALB. Conclusions According to the clinical classification of patients with CHB, serum HBV DNA load level has different dynamic change with RBP and ALB. For e+-CHB patients, HBV DNA load change has no significant relation with RBP and ALB. For e--CHB patients, HBV DNA load change significantly associates with the degree of liver damage. In addition, the serum RBP can better reflect the damage level of liver function than ALB. In the liver function damage, RBP is superior to ALB.